Cover Image

Preliminary Experience With Low Molecular Weight Heparin Strategy in COVID-19 Patients

BackgroundHeparin administration in COVID-19 patients is recommended by expert consensus, although evidence about dosage, duration and efficacy are limited. We aim to investigate the association between different dosages of low molecular weight heparin (LMWH) and mortality among COVID-19 hospitalize...

Full description

Saved in:

Bibliographic Details
Main Authors:	Pasquale Paolisso (Author), Luca Bergamaschi (Author), Emanuela Concetta D'Angelo (Author), Francesco Donati (Author), Maddalena Giannella (Author), Sara Tedeschi (Author), Renato Pascale (Author), Michele Bartoletti (Author), Giulia Tesini (Author), Mauro Biffi (Author), Benilde Cosmi (Author), Carmine Pizzi (Author), Pierluigi Viale (Author), Nazzareno Galié (Author)
Format:	Book
Published:	Frontiers Media S.A., 2020-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Opportunistic infections in end stage liver disease
by: Michele Bartoletti, et al.
Published: (2018)

Secondary Prevention Medical Therapy and Outcomes in Patients With Myocardial Infarction With Non-Obstructive Coronary Artery Disease
by: Pasquale Paolisso, et al.
Published: (2020)

A Proof of Concept of the Usefulness of a TDM-Guided Strategy for Optimizing Pharmacokinetic/Pharmacodynamic Target of Continuous Infusion Ampicillin-Based Regimens in a Case Series of Patients with Enterococcal Bloodstream Infections and/or Endocarditis
by: Milo Gatti, et al.
Published: (2022)

Epidemiology of Meropenem/Vaborbactam Resistance in KPC-Producing <i>Klebsiella pneumoniae</i> Causing Bloodstream Infections in Northern Italy, 2018
by: Paolo Gaibani, et al.
Published: (2021)

The Potential Role of Heparin in Patients With COVID-19: Beyond the Anticoagulant Effect. A Review
by: Lucia Gozzo, et al.
Published: (2020)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant <i>Pseudomonas aeruginosa</i> Bloodstream Infections and/or Hospital-Acquired Pneumonia
by: Milo Gatti, et al.
Published: (2022)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
by: Pier Giorgio Cojutti, et al.
Published: (2021)

Assessment of a PK/PD Target of Continuous Infusion Beta-Lactams Useful for Preventing Microbiological Failure and/or Resistance Development in Critically Ill Patients Affected by Documented Gram-Negative Infections
by: Milo Gatti, et al.
Published: (2021)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like <i>Klebsiella pneumoniae</i> Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
by: Pier Giorgio Cojutti, et al.
Published: (2022)

Reply to SGLT-2 inhibitors: Post-infarction interventional effects
by: Pasquale Paolisso, et al.
Published: (2023)

Impact of Inflammation on Voriconazole Exposure in Critically ill Patients Affected by Probable COVID-19-Associated Pulmonary Aspergillosis
by: Milo Gatti, et al.
Published: (2023)

Use of Enoxaparin to Counteract COVID-19 Infection and Reduce Thromboembolic Venous Complications: A Review of the Current Evidence
by: Filippo Drago, et al.
Published: (2020)

Heparin, Low Molecular Weight Heparin, and Non-Anticoagulant Derivatives for the Treatment of Inflammatory Lung Disease
by: Janis Kay Shute
Published: (2023)

Heparin Mimetics: Their Therapeutic Potential
by: Shifaza Mohamed, et al.
Published: (2017)

Heparin: Past, Present, and Future
by: Eziafa I. Oduah, et al.
Published: (2016)

To be or not to be a case of heparin resistance
by: Jibran Durrani, et al.
Published: (2018)

HEPARIN-INDUCED THROMBOCYTOPENIA (REVIEW)
by: S. A. Vasiliev, et al.
Published: (2019)

The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes
by: Alex C Spyropoulos, et al.
Published: (2008)

Heparin interferes with the uptake of liposomes in glioma
by: Thomas S. van Solinge, et al.
Published: (2023)

Heparin Induced Osteoporosis Following Pregnancy
by: Pınar Akpınar, et al.
Published: (2016)

Heparin-Induced Thrombocytopenia in COVID-19
by: Prasanth Lingamaneni MD, et al.
Published: (2020)

Effects of low-molecular-weight heparin and unfractionated heparin on patients with exertional heat stroke with thrombocytopenia: A prospective study
by: Li Cheng, et al.
Published: (2019)

Heparin and Heparin-Based Drug Delivery Systems: Pleiotropic Molecular Effects at Multiple Drug Resistance of Osteosarcoma and Immune Cells
by: Natalia Todosenko, et al.
Published: (2022)

Does Cytokine-Release Syndrome Induced by CAR T-Cell Treatment Have an Impact on the Pharmacokinetics of Meropenem and Piperacillin/Tazobactam in Patients with Hematological Malignancies? Findings from an Observational Case-Control Study
by: Chun Liu, et al.
Published: (2023)

Heparin-induced thrombocytopenia associated with low-molecular-weight heparin: clinical feature analysis of cases and pharmacovigilance assessment of the FAERS database
by: Leping Liu, et al.
Published: (2023)

Strategies to Overcome Heparins' Low Oral Bioavailability
by: Ana Rita Neves, et al.
Published: (2016)

Prescriber perceptions of the safety and efficacy of unfractionated heparin versus low molecular weight heparin in the acute treatment phase: a qualitative study
by: Danielle Green, et al.
Published: (2024)

An Improvement in the Antimicrobial Resistance Patterns of Urinary Isolates in the Out-Of-Hospital Setting following Decreased Community Use of Antibiotics during the COVID-19 Pandemic
by: Sara Tedeschi, et al.
Published: (2023)

Occurring of In Vitro Functional Vasculogenic Pericytes from Human Circulating Early Endothelial Precursor Cell Culture
by: Silvia Cantoni, et al.
Published: (2015)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin-Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
by: Pasquale Maria Berrino, et al.
Published: (2023)

An Ovarian Cancer Patient Presenting Heparin - Induced Thrombocytopenia after use of Low - Molecular - Weight Heparin: A Case Report of Rare Condition
by: Yasin Durmuş, et al.
Published: (2019)

Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021)

COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis
by: Alessandra F. Perna, et al.
Published: (2020)

Advanced delivery strategies facilitating oral absorption of heparins
by: Guihua Fang, et al.
Published: (2020)

Life-threatening hemorrhage following subcutaneous heparin therapy
by: Jana Hudcova, et al.
Published: (2008)

Multifaceted Heparin: Diverse Applications beyond Anticoagulant Therapy
by: Razia Sultana, et al.
Published: (2024)

Heparin Mimetics and Their Impact on Extracellular Matrix Protein Assemblies
by: Fabian Heide, et al.
Published: (2023)

Tips on drawing blood through a heparin lock
by: Akram Ghaemmaghami
Published: (1993)

Survey among Italian experts on existing vaccines' role in limiting antibiotic resistance
by: Federico Marchetti, et al.
Published: (2021)

Durability of the two-lumen catheter in hemodialysis patients; Ethanol 70%-heparin versus cefazolin-heparin: a randomized, double-blind clinical trial study
by: Hadi Yousefi, et al.
Published: (2023)